HLTF and cancer: It has been suggested that the loss of expression of HLTF in several cancers (colon, gastric, esophageal, cervix, lung, hepatocellular, and bladder) may be caused by promoter methylation, as the downregulation of HLTF is correlated with hypermethylation of the promoter region [86,167,179].